Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Betahistine Mesylate

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Betahistine Mesylate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical
    Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical

    30 Mar 2024

    // ACNNEWSWIRE

    https://www.acnnewswire.com/press-release/english/89970/eisai-to-divest-rights-for-merislon-and-myonal-in-japan-to-kaken-pharmaceutical

    ACNNEWSWIRE
    30 Mar 2024
    Share Share
    DKSH inks agreement to acquire pharma brands, Myonal & Merislon from Eisai
    DKSH inks agreement to acquire pharma brands, Myonal & Merislon from Eisai

    08 Nov 2022

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=154325&sid=2

    PHARMABIZ
    08 Nov 2022
    Share Share